Last reviewed · How we verify

Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting

NCT02473887 Phase 1 COMPLETED

The purpose of this study is to give children with gastroenteritis with persistent vomiting flavored intravenous ondansetron orally. The investigators test the palatability of the drug and check the serum level of ondansetron at 4 hours .

Details

Lead sponsorHamad Medical Corporation
PhasePhase 1
StatusCOMPLETED
Enrolment40
Start date2014-09
Completion2015-01

Conditions

Interventions

Primary outcomes